Genetic Editing will be needed for a lot of genetic related problems and diseases. The ability to find mutated, or faulty gene, unpair and pair with a new genetic information without affecting a perfectly ok DNA is impressive. Hopefully, in few years, it will become ready for diagnostics and would be able to solve Sickle Cell Disease.
The wide acceptance and use of the CRISPR technology of genome editing cab be attributed to the fact that, it much more robust and easier to use compared to other methods of genomic engineering. Drug manufacturing sector was not left out of the technology.
While it is fast and easy, cost is one of the reasons why a lot of science technological devices haven't reached mass adoption.
I concur with you on this.
Though most times, competition tend to reduce the cost at the long run.
But for the time being, let the rich flex their muscle.
That's true. The rich in developed countries will flex their muscles, followed by the masses in developed countries, then it would find its way down to developing countries in years or maybe decades. Ventilator is a very good example. If it weren't for Covid-19, so many hospitals in developing countries won't have good, functioning ventilators.